GNMX Aevi Genomic Medicine, Inc.

5.08
+0  (0%)
Previous Close 5.08
Open 5.10
Price To book 4.40
Market Cap 188.45M
Shares 37,097,000
Volume 111,684
Short Ratio 4.78
Av. Daily Volume 181,038

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b data due 1H 2017.
NFC-1
22q11.2 Deletion Syndrome
Phase 2/3 completion of enrollment announced January 4, 2017. Data are due 1Q 2017.
NFC-1 - SAGA
mGluR mutation positive ADHD